Mindray Medical International Limited ADR R (MR): Today's Featured Health Services Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Mindray Medical International Limited ADR r ( MR) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day up 1.2%. By the end of trading, Mindray Medical International Limited ADR r fell $1.06 (-3.0%) to $34.93 on average volume. Throughout the day, 882,202 shares of Mindray Medical International Limited ADR r exchanged hands as compared to its average daily volume of 1,099,600 shares. The stock ranged in price between $34.50-$35.75 after having opened the day at $35.68 as compared to the previous trading day's close of $35.99. Other companies within the Health Services industry that declined today were: Dehaier Medical Systems ( DHRM), down 17.0%, Liberator Medical Holdings ( LBMH), down 11.6%, SunLink Health Systems ( SSY), down 7.3% and Kips Bay Medical ( KIPS), down 6.2%.

Mindray Medical International Limited, through its subsidiary, Shenzhen Mindray, develops, manufactures, and markets medical devices worldwide. It operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products, and Medical Imaging Systems. Mindray Medical International Limited ADR r has a market cap of $4.3 billion and is part of the health care sector. Shares are down 1.0% year to date as of the close of trading on Wednesday. Currently there are 5 analysts that rate Mindray Medical International Limited ADR r a buy, 1 analyst rates it a sell, and 1 rates it a hold.

TheStreet Ratings rates Mindray Medical International Limited ADR r as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, reasonable valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the positive front, Psychemedics Corporation ( PMD), up 12.0%, Rockwell Medical ( RMTI), up 9.5%, InfuSystems Holdings ( INFU), up 9.3% and Vision-Sciences Inc (DE ( VSCI), up 9.0% , were all gainers within the health services industry with Thermo Fisher Scientific ( TMO) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

3 Fallen Angels With Chart Appeal

3 Fallen Angels With Chart Appeal

3 Stocks Driving The Health Services Industry Higher

Mindray Medical (MR) Stock Gains After Receiving 'Going Private' Proposal

Trade-Ideas: Mindray Medical International (MR) Is Today's Weak On High Relative Volume Stock

Mindray Medical International (MR) Downgraded From Buy to Hold